2Xideas’s Bio-Techne TECH Stock Holding History

2Xideas’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.74M	Sell	24,613 -8,799	-26%	-$475K	0.75%	29
2026 Q1	$1.75M	Sell	33,412 -1,501	-4%	-$90.1K	0.68%	36
2025 Q4	$2.05M	Sell	34,913 -12,909	-27%	-$784K	0.58%	48
2025 Q3	$2.66M	Sell	47,822 -21,436	-31%	-$1.15M	0.56%	47
2025 Q2	$3.56M	Sell	69,258 -1,503	-2%	-$75.5K	0.61%	50
2025 Q1	$4.15M	Buy	70,761 +40,820	+136%	+$2.77M	0.63%	52
2024 Q4	$2.16M	Sell	29,941 -77,152	-72%	-$5.67M	0.29%	59
2024 Q3	$8.56M	Buy	+107,093	New	+$8.05M	1.15%	33

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

2Xideas's TECH Position: Q2 2026 in Review

2Xideas reduced its Bio-Techne (TECH) stake by 26% in Q2 2026, selling an estimated $475K and leaving 24,613 shares worth $1.74M. The position accounts for 0.75% of the portfolio, ranked #29.

2Xideas first reported a position in TECH in Q3 2024 and has held it in 8 quarters since. The position peaked at $8.56M in Q3 2024. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

2Xideas held 24,613 shares of Bio-Techne worth $1.74M as of Q2 2026.
2Xideas sold 8,799 Bio-Techne shares in Q2 2026, an estimated $475K.
Bio-Techne made up 0.75% of 2Xideas's portfolio in Q2 2026, its #29 holding.
2Xideas first reported a position in Bio-Techne in Q3 2024 and has held it in 8 quarters since.
2Xideas's Bio-Techne position peaked at $8.56M in Q3 2024.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on 2Xideas's 13F filing for Q2 2026, filed 14 Aug 2026.